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ABSTRACT
Objectives: The aim of the study is to verify the usefulness of a real-time polymerase chain reaction versus the culture for 
ante- and intrapartum group B Streptococcus maternal colonization (GBS) and prevalence of discordance during the period 
between an antepartum screening and delivery.
Material and methods: The study involved 106 pregnant women aged 18 to 39 years. Rectovaginal samples were collected 
according to CDC guidelines at 35–37 weeks of gestation as well as in the first stage of labour, during physical examina-
tion and were analyzed using two independent diagnostic methods: microbiological culture with standard culture and 
polymerase chain reaction with real-time assay. 
Results: The discordance between antenatal and intrapartum GBS prevalence has been demonstrated as well as differences 
associated with diagnostic strategies, culture and PCR. 
Conclusions: Intrapartum detection of GBS colonization using culture or Real-Time PCR assay as well, regardless of antenatal 
screening test for GBS, is very useful in identifying women who require implementation or withdrawal from prophylactic 
intrapartum antibiotic therapy. Real-Time PCR is a quick efficient method for GBS screening in pregnant women, which 
can be even applied during labor due to its short time of analyzing and high sensitivity and specificity. The above fact may 
indicate the need to perform the GBS test in the intrapartum period in all pregnant GBS negative women using PCR assay 
as a more adequate diagnostic method as the procedure could reduce the risk of a neonatal GBS infection subsequently 
to a prophylactic antibiotic therapy in women with an intrapartum positive GBS.
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INTRODUCTION
Group B Streptococcus (GBS) are β-hemolytic, Gram-pos-
itive bacteria that are a leading cause of neonatal infections 
and maternal GBS colonization during pregnancy is associ-
ated with a higher incidence of ascending infection or GBS 
transfer to the newborn during labor [1]. An independent 
risk factor for GBS colonization in pregnant women is gesta-
tional diabetes [2]. The GBS direct contact with amniotic cav-
ity or placenta may lead to inflammation of the membranes 
which is associated with premature birth or stillbirth [3–6]. 
In addition, group B Streptococcus is the leading cause of 
sepsis and meningitis in the first 3 months of life [7, 8] and in 
1 to 3% of children it may cause a severe early-onset group 
B Streptococcus infection within seven days after birth, with 
a neonatal mortality rate of around 12% [9]. It is estimated 
that the incidence of women with vaginal/rectal GBS coloni-
zation is 30% and the infection is mostly asymptomatic [10]. 
The GBS culture identification using microbiological meth-
ods with swabbing from the vaginal and rectal area remains 
the gold standard [11, 12]. The results are obtained after 
48–72 hours and have low predictive value of the positive 
result [13]. As a GBS colonization in pregnancy remains 
the most important risk factor for newborn disease due its 
vertical transmission during delivery, the time of GBS detec-
tion with immediate antibiotic prophylaxis implementation 
plays a crucial role. Many assays focus therefore on GBS 
screening in attempt to validate the fastest and the most 
effective method. Real-Time PCR screening during labor has 
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the advantage of providing results within 1–2 hours with 
high specificity and sensitivity.
Recently the Cepheid Xpert GBS kit in the GeneXpert® 
Dx system is found to have been used as a GBS screening 
method. An automated PCR-assay with vaginal/rectal swab 
testing for GBS during labor may reduce the incidence of un-
necessarily given intrapartum antibiotic prophylaxis (IAP) as 
well as can be useful for the selection of women to whom IAP 
should be offered, due to its high sensitivity of 85.71–89% 
and specificity of 90–95.9% [14–16].
Objectives
The aim of the study is to verify the usefulness of a re-
al-time polymerase chain reaction versus the culture for 
ante- and intrapartum group B Streptococcus maternal 
colonization (GBS) and prevalence of discordance during 
the period between an antepartum screening and a delivery.
MATERIAL AND METHODS
The study involved 106 women aged from 18 to 39 years 
(mean 29.1 ± 4.9) giving birth at the Department of Peri-
natology, Obstetrics and Gynecology in Szczecin, Poland 
in the period 01.10–30.10.2018 and their children (Tab. 1). 
The inclusion criterion was current term pregnancy (from 
37 weeks to 42 weeks), preliminary qualification for vaginal 
route delivery and the presentation of microbial culture 
for GBS, taken from vagina/rectal area as a part of rou-
tine screening test performed between 35 and 37 weeks 
of gestation. This investigation did an analysis to establish 
the prevalence and discordance of GBS colonization among 
Caucasian women.
Rectovaginal samples were collected from all pregnant 
women being in the intrapartum period according to CDC 
guidelines, during a physical examination and were ana-
lyzed using two independent diagnostic methods: micro-
biological culture with standard culture and Real-Time PCR 
analysis. The material was taken from the vaginal vestibule 
(without using vaginal speculum) and anus (above the exter-
nal sphincter) using sterile swabs, appropriate for the given 
method of determination. After delivery, newborns swabs 
were taken from the ear and anus and standard culture was 
performed for bacterial strains identification.
A specimen collection and microbiological culture.
Swabs were collected on a transport medium, not con-
taining activated carbon. In the laboratory, the swabs were 
used to inoculate two culture tubes and transferred into the 
tamped medium with addition of gentamicin Todd-Hewitt 
(8 μg/mL) and nalidixic acid (15 μg/mL). Secondary cultures 
were incubated for 24–48 h at 35–37°C on air or in a 5% en-
riched atmosphere (5% CO2). After an incubation operation, 
a small number of cultures were streaked on an improved 
solid medium (5% sheep blood agar plates). The plates 
were re-incubated for 18–24 hours at 35–37°C on air or 
in a 5% enriched atmosphere (5% CO2). After gaining the 
GBS-corresponding colony grow (characteristic narrow zone 
of beta-hemolysis), the Gram-positive, catalase-negative 
grains were identified. In doubtful cases, the CAMP (Christi, 
N. E. Atkins i E. Munch-Peterson) test were used for presump-
tive identification of Group B beta-hemolytic streptococci, 
Streptococcus agalactiae.
For the rapid identification of GBS colonization, in vitro 
diagnostic tests were used to detect GBS DNA from en-
riched vaginal and rectal specimens. The Xpert GBS tests of 
the Cepheid Xpert GBS system were used for this purpose 
based on a fully automated Real-Time PCR polymerase 
chain reaction with fluorogenic detection of the amplified 
DNA. After collecting the swab, it was placed in Lim broth 
for the enrichment and a secondary clean swab (Cepheid) 
dipped into the enrichment broth specimen was put in 
the designated chamber of the cartridge. Once the DNA 
solution is obtained, mixing with dry PCR reagents is per-
formed. After the transfer into the integrated reaction tube 
for real-time PCR, the GBS detection takes place. On the 
base of fluorescent signals measurement and embedded 
calculation algorithms, the GeneXpert Instrument Systems 
interpolates the results. A fully automated GBS detection 
procedure using GeneXpert Instrument Systems takes 
about 75 minutes and the results are presented in the 
tables and graphically.
The sensitivity, specificity, positive predictive value and 
negative predictive value of the Real-Time PCR assay were 
separately counted with the antepartum or intrapartum 
culture as the reference. A Fisher’s exact test was used for 
statistical significance (p > 0.05) and to analyze the differ-
ences among group means in a sample, the analysis of 
variance (ANOVA) has been used. Statistical analyses were 
performed with the use of MacStats version 1.01.
Table 1. Maternal and neonatal demographic characteristics
Age (years) 29.1 ± 4.9
Nullipara n (%) 66 (62.3)
Maternal weight at delivery (kg) 79.5 ± 12.9
Height (cm) 166.2 ± 5.8
BMI (kg/m2) 28.7 ± 4.1
Mean duration of gestation (weeks) 39 ± 1.2
Rupture of membranes > 18 hours n (%) 4 (3.8)
GDM n (%) 22 (20.7)
Cesarean section n (%) 26 (24.5)
Newborns birth weight (g) 3368.7 ± 421.3
Early-onset infection n (%) 2 (1.9)
Late-onset infection n (%) 0 (0)
Data are means ± SD
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RESULTS
Of the 106 pregnant women included in the analysis, in 
29 (27.3%) cases microbiological cultures for GBS collected 
from the vagina/rectum in the antepartum period were posi-
tive, while a negative result was found in 77 (72.7%) preg-
nant women. In the group of antenatal GBS positive women 
(n = 29), a positive result of intrapartum microbiological 
culture from vagina/rectum was obtained in 12 (41.4%) 
women, while the positive result has been confirmed by 
PCR in 20 (69%) women. In the group of antenatal GBS 
positive women, a negative result in intrapartum culture 
was obtained in 17 (58.6%) women, while the PCR showed 
a negative result only in 9 (31%) women (Fig. 1). The positive 
result in an ante- and intrapartum test confirmed by two 
methods (culture, PCR) was demonstrated in 10 (34.5%) of 
29 women. On the other hand, the conversion from GBS 
positive test to negative GBS test in the intrapartum period 
confirmed by two methods (culture, PCR) was demonstrated 
in 7 (24.1%) of 29 women. In 10 (34.5%) cases of 29 GBS 
positive women in the antepartum period, the intrapartum 
GBS test was negative in culture and positive in PCR, while 
in 2 (6.9%) cases the intrapartum GBS test was positive in 
culture and negative in PCR (Tab. 1). In all women with 
a positive result of antepartum GBS, no GBS infection was 
found in newborns regardless of maternal intrapartum GBS 
status. In the group of GBS negative women in antepar-
tum screening (n = 77), a positive result of intrapartum 
culture was obtained in 8 (10.4%) women, while the PCR 
test was positive in 9 (11.7%) women. In one case, where the 
conversion of antepartum negative to positive result con-
firmed in both the culture and PCR was demonstrated, the 
newborn was born with GBS infection but did not develop 
sepsis in the further course of the disease. In the group of 
women with negative GBS test in the antepartum period, 
the negative result in intrapartum culture was obtained 
in 69 (89.6%) women whereas the PCR showed a nega-
tive result in 68 (88.3%) women (Fig. 1). Paradoxically, in 
one case, in which ante- and intrapartum tests (culture 
and PCR) were negative for GBS, the newborn was born 
with a GBS infection but did not develop sepsis in the fur-
ther course of the disease. Also, in one case with maternal 
negative ante- and intrapartum GBS culture and negative 
intrapartum PCR but positive intrapartum culture, a GBS 
infection was found in the newborn which did not result in 
sepsis. The assessment of the diagnostic reliability of used 
methods is presented in Table 2. The study shows that the 
diagnosis of GBS colonization using PCR method indicates 
a high sensitivity in those women in whom GBS was found 
to be present in intrapartum culture screening. The lack of 
colonization of GBS detected by PCR assay equally applies 
to women in whom the presence of GBS in the culture has 
not been demonstrated before delivery as well as in an in-
trapartum test, showing a high specificity in this respect. The 
analysis of variance did not show any relationship between 
GBS positive tests (antenatal and intrapartum culture and 
PCR assay) and the occurrence of gestational diabetes mel-
litus. The correlation between GBS colonization and the time 
of premature rupture of membranes has not been proved 
as well. Regardless of the time that passed from premature 
rupture of membranes (PROM) and the way of delivery 
(a vaginal vs cesarean section), the tendency to colonize 
with GBS was similar.
DISCUSSION
Based on a cohort study conducted in the period 2003–
–2015 in 60029 pregnant women, colonization with GBS 
streptococcus was found in 21.6% of women, GBS negative 
was demonstrated in 78.3% and invasive symptomatic GBS 
infection was detected in 0.1% of pregnant women [17]. In 
our material, the percentage of colonized pregnant women 
was similar and amounted to 27.3%, while the negative result 
was found in 72.7% of cases. There was no case of sympto-
matic GBS infection in women. Regardless of the presence of 
Table 3. Sensitivity, specificity, and predictive values for the PCR 
assay and culture screening for the detection of GBS in the cohort 






Positive predictive value (PPV) 75.9 62.1
Negative predictive value (NPV) 84.4 94.8
Table 2. Group B Streptococcus status of 106 pregnant women 



















































GBS infection of 
newborn None *1 (1.3) *1 (1.3)
A-CS — Antepartum culture screening; I-CS — Intrapartum culture screening; 
I-PCR — Intrapartum PCR assay
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GBS colonization in the rectovaginal area (chronic, transient 
or intermittent) in both pregnant and non-pregnant women, 
its incidence is within 15–35% [18]. Young BC et al. demon-
strated differences in the occurrence of GBS colonization, 
depending on the time when samples were collected for 
culture. When a swab was taken in the antenatal period, GBS 
positive results were found in 19.5% of women, compared 
with 23.8% of women who had performed the intrapartum 
GBS screening test. It has been demonstrated that there is 
a discordance of GBS cultures collected in the antenatal pe-
riod and those collected in the intrapartum period, amount-
ing to as much as 10.4% [18–20]. We obtained similar results 
in our investigation where among 77 women GBS negative 
in the antenatal period, the positive culture test was found in 
8 (10.39%) and positive PCR assay in 9 (11.69%) individuals. It 
is reported that the antenatal microbiological screening test 
has the sensitivity of about 60% and a relatively low specific-
ity [16, 19–21]. Our studies confirmed a high sensitivity of 
intrapartum PCR assay when compared to antenatal culture, 
which is consistent with other studies [22–25]. This result is 
important because as it has been shown in Young et al. re-
port, majority of newborns with sepsis was born from women 
with GBS negative antenatal screening test and subsequently 
without the IAP [18]. In our material, among 3 newborns born 
with GBS infection, 2 newborns came from GBS negative 
mothers in the antenatal period who did not receive IAP. 
The above fact may indicate the need to perform the GBS 
test in the intrapartum period in all pregnant GBS negative 
but also positive women. The above procedure could reduce 
the risk of neonatal infection in women with conversion to 
positive GBS in which IAP has been implemented. In turn, in 
the group of women with antenatal false-positive GBS result, 
GBS intrapartum assay would be conclusive, especially when 
performed using PCR assay and could reduce the incidence 
of unnecessary IAP. When taking the time of procedure for 
consideration, the use of Cepheid Xpert GBS is a more ad-
equate method for rapid GBS colonization detection as well 
as facilitating qualification for antibiotic prophylaxis during 
labor [1]. In the Plaivert et al. [22] studies, out of 565 women 
with antenatal positive GBS, only 335 (59.3%) confirmed GBS 
presence in the intrapartum test regardless of a diagnostic 
method which proves the unnecessary use of prophylactic 
antibiotics in almost 40% of women. Our results turned out 
to be even more unsatisfactory. Among antenatally colo-
nized women only 41.4% confirmed the GBS presence in 
intrapartum PCR assay. According to the literature, a GBS 
identification using PCR is a sensitive and specific method 
acceptable for an intrapartum GBS screening [22, 23]. The 
meta-analysis of intrapartum GBS colonization conducted 
among 6368 pregnant women in 15 studies showed high 
sensitivity (93.7%) and specificity (97.6%) of the PCR assay 
in relation to the microbiological methods which due to 
rapid result determines the PCR superiority [26]. Also, in our 
investigation, despite the relatively small analyzed group, 
the PCR method proved to be a useful diagnostic tool dur-
ing delivery. According to Helmig et al. an intrapartum PCR 
assay is an adequate diagnostic tool to qualify patients for 
prophylactic antibiotic therapy [23]. In our study, the rela-
tionship between two variables: time elapsed from PROM 
to delivery and incidence of GBS colonization has not been 
confirmed regardless of the diagnostic method used (PCR, 
culture), which is consistent with studies of other investiga-
tors [27]. In a study conducted by Victoria Parente et al. [28], 
an early fetal rupture of membranes over 18 hours was as-
sociated with a slightly higher chance of occurrence of GBS 
colonization (OR 1.38).
CONCLUSIONS
We conclude that intrapartum detection of GBS coloni-
zation using culture or Real-Time PCR assay as well, regard-
less of antenatal screening test for GBS, is very useful in 
identifying women who require implementation or with-
drawal from prophylactic intrapartum antibiotic therapy. 
Real-Time PCR is a quick efficient method for GBS screening 
in pregnant women, which can be even applied during 
labor due to its short time of analyzing and high sensitivity 
and specificity.
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